ABSTRACT
Abstract Ischemia/reperfusion (IR) injury leads to overproduction of Reactive Oxygen Species (ROS), and disrupts membrane potential that contributes to cell death. The aim of this study was to determine if naringin (NAR), trimetazidine (TMZ) or their combination, protect the kidney mitochondrial from IR injury. Forty rats were randomly allocated into five groups, harboring eight rats each: Sham, IR, NAR (100 mg/kg), TMZ (5 mg/kg) and NAR plus TMZ. Ischemia was induced by obstructing both renal pedicles for 45 min, followed by reperfusion for 4 hours. The mitochondria were isolated to examine the ROS, Malondialdehyde (MDA), Glutathione (GSH), mitochondrial membrane potential (MMP) and mitochondrial viability (MTT). Our findings indicated that IR injury resulted in excessive ROS production, increased MDA levels and decreased GSH, MMP and MMT levels. However, NAR, TMZ or their combination reversed these changes. Interestingly, a higher protection was noted with the combination of both, compared to each drug alone. We speculate that this combination demonstrates a promising process for controlling renal failure, especially with the poor clinical outcome, acquired with NAR alone. This study revealed that pretreatment their combination serves as a promising compound against oxidative stress, leading to suppression of mitochondrial stress pathway and elevation of GSH level.
Subject(s)
Animals , Male , Rats , Trimetazidine/analysis , Flavanones/analysis , Drug Combinations , Renal Insufficiency/pathology , Ischemia/pathology , Pharmaceutical Preparations/administration & dosage , Cell Death , Oxidative Stress , Mitochondria/classificationABSTRACT
A woman aged 63 years presented at the gynecological oncology outpatient clinic with the following medical history: smoking history (smoking index of 10); systemic arterial hypertension diagnosed 6 years ago; menarche at 16 years; menopause at 52 years; 4 pregnancies, 4 deliveries; beginning of active sexual life at 18 years; 3 sexual partners; and no early cancer detection method in her life. Her performance status per ECOG criteria was 1. The patient presented with transvaginal bleeding with 5 months of evolution. Upon physical exploration, a 5 x 5 cm tumor in the cervix was detected, with the following characteristics: exophytic, friable, bleeding, with invasion to the lower third of the vagina, affection to the cul-de-sac and parametria, and bilaterally fixed to the pelvic wall. A biopsy of the cervix showed moderately differentiated invasive squamous cell carcinoma.
Subject(s)
Carcinoma, Squamous Cell/complications , Carcinoma, Squamous Cell/pathology , Renal Insufficiency/pathology , Uterine Cervical Neoplasms/complications , Uterine Cervical Neoplasms/pathology , Female , Humans , Middle Aged , Neoplasm Invasiveness , Renal Insufficiency/etiologyABSTRACT
BACKGROUND: Severe ischemia-reperfusion injury (SIRI) seems to be the key factor that can significantly affect the function of both native kidneys and renal allografts. Therefore, the development of a successful strategy is of a paramount importance in both basic and clinical research. METHODS: To determine the effects of SIRI on the native kidney function, a murine model was planned as follows: group 1 (n = 6) mice underwent to nephrectomy plus ischemia-reperfusion injury for 30 minutes; group 2 (n = 6) mice underwent to nephrectomy without ischemia-reperfusion injury and thus served as sham controls for SIRI. The results of serum creatinine (SCr) were analyzed using Mann-Whitney U tests to calculate the significance between mean values. Survival between groups was measured by Kaplan-Meier test. RESULTS: To reliably achieve an elevation of SCr levels animals were exposed to a SIRI. The values of SCr increased from 0.35 (SD, 0.09) mg/dL to about 2-fold within 2 days and 3-fold within the following 5 days. Under these given conditions the mice displayed signs and histologic findings of severe kidney damage. The survival rate was about 83% of the animals within a week, and they showed no capacity of complete spontaneous self-regeneration. CONCLUSIONS: In this study, we aim to establish a murine model with extensive structural kidney damage and significant elevation of SCr levels, which could be used in basic and translational research of transplantation and regenerative therapies.
Subject(s)
Disease Models, Animal , Kidney Transplantation , Renal Insufficiency/etiology , Reperfusion Injury/complications , Animals , Creatinine/blood , Kidney/physiopathology , Male , Mice , Mice, Inbred BALB C , Renal Insufficiency/pathology , Renal Insufficiency/physiopathology , Reperfusion Injury/pathology , Reperfusion Injury/physiopathologyABSTRACT
Objectives. This study sought to compare the estimated glomerular filtration rate and the indication of dose adjustment of antimicrobials when using Cockcroft-Gault or Modification of Diet in Renal Disease. Methods. A cross-sectional study was performed with patients admitted to the intensive care unit of a Brazilian general hospital. The glomerular filtration rate was calculated for patients on all days using the Cockcroft-Gault and Modification of Diet in Renal Disease equations. The difference in estimated glomerular filtration and the dose adjustment indication of antimicrobials were assessed. Results. A total of 631 patients were included in this study. The median estimated glomerular filtration was significantly higher when estimated using Modification of Diet in Renal Disease (100.3 mL/ min/1.73 m2) than the estimation by Cockcroft-Gault (83.2 mL/min) [p<0.001]. Greater differences in estimations produced by the two formulae were observed in patients at extremes of weight and age, and a different dose adjustment was indicated for all antimicrobials assessed. Conclusions. These results demonstrate a significant difference in estimated glomerular filtration rate values when calculated using either Cockcroft-Gault or Modification of Diet in Renal Disease as well as in the indication of dose adjustment in an intensive care unit
Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Patients , Brazil/ethnology , Dosage/analysis , Glomerular Filtration Rate , Intensive Care Units/classification , Pharmaceutical Preparations , Cross-Sectional Studies , Diet/classification , Renal Insufficiency/pathologyABSTRACT
The cryoglobulinemic syndrome is produced by precipitating immunoglobulins at low temperatures. Its production is associated with several causes, such as lymphoproliferative disorders, chronic infections and autoimmune disorders. However, the etiology is unknow. There are three types of cryoglobulins. Type II and III are the mixed. Type III produce a systemic vasculitis with diverse clinical manifestations. Palpable purpura is the most common, accompanied by arthralgia, neuropathy and type I membranoproliferative glomerulonephritis. We present a case of a 71 years old male patient with renal failure, nephritic syndrome, arterial hypertension and palpable purpuric skin lesions in members, thorax and abdomen. During hospitalization essential mixed cryoglobulinemia associated with cutaneous leukocytoclastic vasculitis and type I membranoproliferative glomerulonephritis was diagnosed. Complementary methods, treatment instituted and the patient's clinical course are described.
El síndrome crioglobulinémico es producido por inmunoglobulinas que precipitan reversiblemente a bajas temperaturas, llamadas crioglobulinas. Su producción se asocia a varias causas, como desórdenes linfoproliferativos, infecciones crónicas y trastornos autoinmunitarios. No obstante, en muchos casos la etiología no logra determinarse. Existen tres tipos, siendo las de tipo II y III las que forman parte de las denominadas crioglobulinemias mixtas. Estas últimas producen un cuadro de vasculitis sistémica con manifestaciones clínicas diversas. La púrpura palpable es la más frecuente, acompañada en forma variable por artralgias, neuropatía y afección renal en forma de glomerulonefritis membranoproliferativa de tipo I. Presentamos el caso clínico de un paciente de sexo masculino de 71 años de edad con insuficiencia renal, síndrome nefrítico, hipertensión arterial y lesiones cutáneas purpúricas palpables ambos miembros, tórax y abdomen. Durante la internación se diagnostica crioglobulinemia mixta esencial asociada a vasculitis leucocitoclástica cutánea y glomerulonefritis membranoproliferativa tipo I. Describimos los métodos complementarios utilizados para llegar al diagnóstico, el tratamiento instituido y la evolución clínica del paciente.
Subject(s)
Cryoglobulinemia/pathology , Systemic Vasculitis/pathology , Aged , Biopsy , Fatal Outcome , Glomerulonephritis, Membranoproliferative/pathology , Humans , Male , Renal Insufficiency/pathology , Skin/pathology , SyndromeABSTRACT
ABSTRACT Introduction Sepsis is an inflammatory reaction to bacteria involving the whole body and is a significant cause of mortality and economic costs. The purpose of this research was to determine whether tadalafil exhibits a preventive effect on sepsis in a septic model induced in rats with cecal ligation and puncture (CLP). Materials and Methods Rats were randomly separated into groups, 10 rats in each: (i) a sham (control) group, (ii) an untreated sepsis group, (iii) a sepsis group treated with 5mg/kg tadalafil and (iv) a sepsis group treated with 10mg/kg tadalafil. A polymicrobial sepsis model was induced in rats using CLP. Rats were sacrificed after 16h, and blood and kidney tissues were collected for biochemical and histopathological study. Results Levels of the inflammatory parameter IL-6 decreased significantly in the sepsis groups receiving tadalafil in comparison with the untreated sepsis group (p<0.05). In terms of histopathology, inflammation scores investigated in kidney tissues decreased significantly in the sepsis groups receiving tadalafil compared to the untreated sepsis group (p<0.05). In addition, levels of creatinine and cystatin C measured in septic rats receiving tadalafil were lower by a clear degree than in septic rats (p<0.05). Conclusion In this study, tadalafil exhibited a preventive effect for sepsis-related damage by suppressing inflammation in serum and kidney tissue of septic rats in a polymicrobial sepsis model induced with CLP.
Subject(s)
Animals , Male , Sepsis/complications , Sepsis/prevention & control , Renal Insufficiency/etiology , Renal Insufficiency/prevention & control , Phosphodiesterase 5 Inhibitors/therapeutic use , Tadalafil/therapeutic use , Reference Values , Spectrophotometry , Superoxide Dismutase/analysis , Calcitonin/blood , Enzyme-Linked Immunosorbent Assay , Immunohistochemistry , Catalase/analysis , Random Allocation , Reproducibility of Results , Interleukin-6/blood , Rats, Wistar , Peroxidase/analysis , Sepsis/pathology , Creatinine/blood , Disease Models, Animal , Renal Insufficiency/pathology , Cystatin C/blood , Kidney/drug effects , Kidney/pathology , Ligation , Malondialdehyde/analysisABSTRACT
Envenomation by Loxosceles spider can result in two clinical manifestations: cutaneous and systemic loxoscelism, the latter of which includes renal failure. Although incidence of renal failure is low, it is the main cause of death, occurring mainly in children. The sphingomyelinase D (SMase D) is the main component in Loxosceles spider venom responsible for local and systemic manifestations. This study aimed to investigate the toxicity of L. intermedia venom and SMase D on kidney cells, using both In vitro and in vivo models, and the possible involvement of endogenous metalloproteinases (MMP). Results demonstrated that venom and SMase D are able to cause death of human kidney cells by apoptosis, concomitant with activation and secretion of extracellular matrix metalloproteases, MMP-2 and MMP-9. Furthermore, cell death and MMP synthesis and secretion can be prevented by tetracycline. In a mouse model of systemic loxoscelism, Loxosceles venom-induced kidney failure was observed, which was abrogated by administration of tetracycline. These results indicate that MMPs may play an important role in Loxosceles venom-induced kidney injury and that tetracycline administration may be useful in the treatment of human systemic loxoscelism.
Subject(s)
Phosphoric Diester Hydrolases/toxicity , Protective Agents/therapeutic use , Renal Insufficiency/chemically induced , Renal Insufficiency/drug therapy , Spider Venoms/toxicity , Tetracycline/therapeutic use , Animals , Caspase 3/metabolism , Cell Line , Cell Survival/drug effects , Gene Expression/drug effects , Humans , Kidney/drug effects , Kidney/pathology , Male , Matrix Metalloproteinase 2/genetics , Matrix Metalloproteinase 2/metabolism , Matrix Metalloproteinase 9/genetics , Matrix Metalloproteinase 9/metabolism , Mice, Inbred BALB C , Protective Agents/pharmacology , Proteinuria/chemically induced , Renal Insufficiency/pathology , Spiders , Tetracycline/pharmacologyABSTRACT
INTRODUCTION: Sepsis is an inflammatory reaction to bacteria involving the whole body and is a significant cause of mortality and economic costs. The purpose of this research was to determine whether tadalafil exhibits a preventive effect on sepsis in a septic model induced in rats with cecal ligation and puncture (CLP). MATERIALS AND METHODS: Rats were randomly separated into groups, 10 rats in each: (i) a sham (control) group, (ii) an untreated sepsis group, (iii) a sepsis group treated with 5mg/kg tadalafil and (iv) a sepsis group treated with 10mg/kg tadalafil. A polymicrobial sepsis model was induced in rats using CLP. Rats were sacrificed after 16h, and blood and kidney tissues were collected for biochemical and histopathological study. RESULTS: Levels of the inflammatory parameter IL-6 decreased significantly in the sepsis groups receiving tadalafil in comparison with the untreated sepsis group (p < 0.05). In terms of histopathology, inflammation scores investigated in kidney tissues decreased significantly in the sepsis groups receiving tadalafil compared to the untreated sepsis group (p < 0.05). In addition, levels of creatinine and cystatin C measured in septic rats receiving tadalafil were lower by a clear degree than in septic rats (p < 0.05). CONCLUSION: In this study, tadalafil exhibited a preventive effect for sepsis-related damage by suppressing inflammation in serum and kidney tissue of septic rats in a polymicrobial sepsis model induced with CLP.
Subject(s)
Phosphodiesterase 5 Inhibitors/therapeutic use , Renal Insufficiency/etiology , Renal Insufficiency/prevention & control , Sepsis/complications , Sepsis/prevention & control , Tadalafil/therapeutic use , Animals , Calcitonin/blood , Catalase/analysis , Creatinine/blood , Cystatin C/blood , Disease Models, Animal , Enzyme-Linked Immunosorbent Assay , Immunohistochemistry , Interleukin-6/blood , Kidney/drug effects , Kidney/pathology , Ligation , Male , Malondialdehyde/analysis , Peroxidase/analysis , Random Allocation , Rats, Wistar , Reference Values , Renal Insufficiency/pathology , Reproducibility of Results , Sepsis/pathology , Spectrophotometry , Superoxide Dismutase/analysisABSTRACT
Objective. To evaluate the expression of inflammatory markers in experimental renal failure after fetal programming. Methods. The offspring aged two and five months were divided into four groups: CC (control dams, control offspring); DC (diabetic dams, control offspring); CFA (control dams, folic acid offspring, 250 mg/Kg); and DFA (diabetic dams, folic acid offspring). Gene expression of inflammatory markers MCP-1, IL-1, NOS3, TGF-ß, TNF-α, and VEGF was evaluated by RT-PCR. Results. MCP-1 was increased in the CFA and DFA groups at two and five months of age, as well as in DC5 when compared to CC5. There was a higher expression of IL-1 in the CFA2, DFA2, and DC2 groups. There was a decrease in NOS3 and an increase in TNF-α in DFA5 in relation to CFA5. The gene expression of TGF-ß increased in cases that had received folic acid at two and five months, and VEGF decreased in the CFA5 and DFA5 groups. DC5 showed increased VEGF expression in comparison with CC5. Conclusions. Gestational diabetes mellitus and folic acid both change the expression of inflammatory markers, thus demonstrating that the exposure to harmful agents in adulthood has a more severe impact in cases which underwent fetal reprogramming.
Subject(s)
Diabetes Mellitus, Experimental/pathology , Diabetes, Gestational/pathology , Fetal Development/physiology , Folic Acid/pharmacology , Kidney/pathology , Renal Insufficiency/pathology , Animals , Biomarkers/metabolism , Chemokine CCL2/metabolism , Female , Interleukin-1/metabolism , Kidney/immunology , Lymphotoxin-alpha/metabolism , Male , Nitric Oxide Synthase Type III/metabolism , Pregnancy , Rats , Rats, Wistar , Renal Insufficiency/immunology , Tumor Necrosis Factor-alpha/metabolism , Vascular Endothelial Growth Factor A/metabolismABSTRACT
Fabry disease (FD) is an inherited X-linked lysosomal disease that causes renal failure in a high percentage of affected individuals. The eNOS gene encodes for endothelial nitric oxide synthase, which plays an important role in glomerular hemodynamics. This gene has two main polymorphisms (Glu298Asp and 4b/a) that have been studied in the context of many different diseases, including those involving cardiovascular and renal alterations. Considering the lack of information regarding eNOS variants and FD, we investigated whether there were associations between eNOS genetic variants and renal function parameters in Mexican patients with FD and renal impairment. In total, 15 FD patients with renal alterations were included in the present study, and associations between eNOS polymorphisms and renal function parameters (urea, creatinine, and GFR) were evaluated. The Asp298 and 4a alleles of the eNOS gene were found to be significantly associated with increased levels of urea and creatinine, and a decreased glomerular filtration rate in FD patients, and this association behaved in a co-dominant fashion. Our results coincide with previous reports showing an association between these polymorphisms and kidney disease, and along with other studies regarding their role in the nitric oxide pathway, suggest that these variants affect the severity of nephropathy in patients with FD.
Subject(s)
Fabry Disease/genetics , Genetic Predisposition to Disease , Nitric Oxide Synthase Type III/genetics , Renal Insufficiency/genetics , Adult , Creatinine/urine , Fabry Disease/pathology , Fabry Disease/urine , Genetic Association Studies , Genotype , Glomerular Filtration Rate/genetics , Guanine Nucleotide Exchange Factors/urine , Humans , Male , Mexico , Polymorphism, Single Nucleotide , Renal Insufficiency/pathology , Renal Insufficiency/urine , Risk Factors , Urea/urine , ras Guanine Nucleotide Exchange FactorsABSTRACT
Tributyltin chloride (TBT) is an organometallic pollutant that is used as a biocide in antifouling paints. TBT induces several toxic and endocrine-disrupting effects. However, studies evaluating the effects of TBT on renal function are rare. This study demonstrates that TBT exposure is responsible for improper renal function as well as the development of abnormal morphophysiology in mammalian kidneys. Female rats were treated with TBT, and their renal morphophysiology was assessed. Morphophysiological abnormalities such as decreased glomerular filtration rate and increased proteinuria levels were observed in TBT rats. In addition, increases in inflammation, collagen deposition and α-smooth muscle actin (α-SMA) protein expression were observed in TBT kidneys. A disrupted cellular redox balance and apoptosis in kidney tissue were also observed in TBT rats. TBT rats demonstrated reduced serum estrogen levels and estrogen receptor-α (ERα) protein expression in renal cortex. Together, these data provide in vivo evidence that TBT is toxic to normal renal function and that these effects may be associated with renal histopathology complications, such as inflammation and fibrosis.
Subject(s)
Disinfectants/toxicity , Environmental Pollutants/toxicity , Kidney/drug effects , Oxidative Stress/drug effects , Renal Insufficiency/chemically induced , Trialkyltin Compounds/toxicity , Actins/agonists , Actins/metabolism , Animals , Apoptosis/drug effects , Biomarkers/blood , Biomarkers/metabolism , Biomarkers/urine , Collagen/agonists , Collagen/metabolism , Disinfectants/administration & dosage , Dose-Response Relationship, Drug , Endocrine Disruptors/toxicity , Environmental Pollutants/administration & dosage , Estrogen Receptor alpha/antagonists & inhibitors , Estrogen Receptor alpha/metabolism , Estrogens/blood , Female , Fibrosis , Kidney/immunology , Kidney/pathology , Kidney/physiopathology , Mast Cells/drug effects , Mast Cells/immunology , Mast Cells/pathology , Proteinuria/etiology , Rats, Wistar , Renal Insufficiency/immunology , Renal Insufficiency/pathology , Renal Insufficiency/physiopathology , Tin/blood , Toxicokinetics , Trialkyltin Compounds/administration & dosageABSTRACT
Malaria in children is still an important public health problem in endemic areas of South-East Asia and Latin America. Certain forms of the disease, such as Plasmodium vivax severe malaria, are still neglected. This descriptive study assessed the frequency of severe and benign P. vivax infection in Emberá children (<14 years of age) from an endemic municipality in Colombia in 2013, using the WHO criteria. During 2013, 270 Emberá children presented 349 episodes of malaria. From them, 22 (8.1%) presented at least one of the criteria for severe malaria. Some patients with P. vivax presented with severe malaria (severe anemia, renal dysfunction, respiratory distress and seizure). Mixed malaria cases presented more complications than those with monoinfection (OR=5.535; 95%CI 1.81-16.9). In Colombia, few data are available about severe P. vivax malaria in children, especially in the Amerindian ethnic groups. Mixed infections were associated with increased risk of severe malaria. At the same time, detailed and prospective studies are needed to measure the real impact of severe vivax malaria, as was evidenced in this paper.
Subject(s)
Endemic Diseases , Malaria, Vivax/epidemiology , Malaria, Vivax/pathology , Adolescent , Anemia/epidemiology , Anemia/pathology , Child , Child, Preschool , Cities/epidemiology , Coinfection/complications , Coinfection/epidemiology , Coinfection/pathology , Colombia/epidemiology , Cross-Sectional Studies , Female , Humans , Infant , Infant, Newborn , Malaria, Vivax/complications , Male , Prevalence , Renal Insufficiency/epidemiology , Renal Insufficiency/pathology , Respiratory Distress Syndrome/epidemiology , Respiratory Distress Syndrome/pathology , Risk Factors , Seizures/epidemiology , Seizures/pathologyABSTRACT
Introduction/Objective: Ureteral obstruction is a common pathology and causes kidney fibrosis and dysfunction at late period. In this present study, we investigated the antifibrotic and antiinflammatory effects of hydrogen sulfide on kidney damage after unilateral ureteral obstruction (UUO) in rats. Materials and Methods: 24 rats were divided into four groups. Group 1 was control, group 2 was sham, group 3 included rats with UUO and group 4 rats with UUO which were given sodium hydrogen sulfide (NaHS)-exogenous donor of hydrogen sulfide (intraperitoneally 56μmoL/kg/day). After 14 days, rats were killed and their kidneys were taken and blood analysis was performed. Tubular necrosis, mononuclear cell infiltration and interstitial fibrosis were determined histopathologically in a part of the kidneys; nitric oxide (NO), malondialdehyde (MDA) and reduced glutathione (GSH) levels were determined in the other part of the kidneys. Urea-creatinine levels were investigated by blood analysis. Statistical analyses were made by the Chi-square test and one-way analysis of variance (ANOVA). Results: There was no significantly difference for urea-creatinine levels among groups. Pathologically, there was serious tubular necrosis and fibrosis in group 3 and there was significantly decreasing of tubular necrosis and fibrosis in group 4 (p<0.005). Also, there was significantly increase of NO and MDA levels and decrease of GSH levels in group 3 compared to other groups (p<0.005). Conclusions: hydrogen sulfide prevents kidney damage with antioxidant and antiinflammatory effect.
Subject(s)
Animals , Male , Anti-Inflammatory Agents/pharmacology , Hydrogen Sulfide/pharmacology , Renal Insufficiency/prevention & control , Ureteral Obstruction/prevention & control , Anti-Inflammatory Agents/therapeutic use , Creatinine/blood , Disease Models, Animal , Fibrosis , Glutathione/analysis , Hydrogen Sulfide/therapeutic use , Kidney/pathology , Malondialdehyde/analysis , Nitric Oxide/analysis , Oxidative Stress , Random Allocation , Rats, Wistar , Reproducibility of Results , Renal Insufficiency/etiology , Renal Insufficiency/pathology , Time Factors , Urea/blood , Ureteral Obstruction/complicationsABSTRACT
Natural killer T (NKT) cells are a subset of lymphocytes that reacts to glycolipids presented by CD1d. Invariant NKT cells (iNKT) correspond to >90% of the total population of NKTs and reacts to α-galactosylceramide (αGalCer). αGalCer promotes a complex mixture of Th1 and Th2 cytokines, as interferon (IFN)-γ and interleukin (IL)-4. NKT cells and IFN-γ are known to participate in some models of renal diseases, but further studies are still necessary to elucidate their mechanisms. The aim of our study was to analyze the participation of iNKT cells in an experimental model of tubule-interstitial nephritis. We used 8-wk-old C57BL/6j, Jα18KO and IFN-γKO mice. They were fed a 0.25% adenine diet for 10 d. Both adenine-fed wild-type (WT) and Jα18KO mice exhibited renal dysfunction, but adenine-fed Jα18KO mice presented higher expression of kidney injury molecule-1 (KIM-1), tumor necrosis factor (TNF)-α and type I collagen. To analyze the role of activated iNKT cells in our model, we administered αGalCer in WT mice during adenine ingestion. After αGalCer injection, we observed a significant reduction in serum creatinine, proinflammatory cytokines and renal fibrosis. However, this improvement in renal function was not observed in IFN-γKO mice after αGalCer treatment and adenine feeding, illustrating that this cytokine plays a role in our model. Our findings may suggest that IFN-γ production is one of the factors contributing to improved renal function after αGalCer administration.
Subject(s)
Galactosylceramides/administration & dosage , Interferon-gamma/genetics , Nephritis/drug therapy , Renal Insufficiency/drug therapy , Adenine/toxicity , Animals , Antigens, CD1d/biosynthesis , Antigens, CD1d/genetics , Collagen Type I/biosynthesis , Hepatitis A Virus Cellular Receptor 1 , Humans , Interleukin-4/biosynthesis , Interleukin-4/genetics , Kidney Tubules/drug effects , Kidney Tubules/pathology , Membrane Proteins/biosynthesis , Membrane Proteins/genetics , Mice , Mice, Knockout , Natural Killer T-Cells/drug effects , Natural Killer T-Cells/immunology , Nephritis/chemically induced , Nephritis/genetics , Nephritis/pathology , Renal Insufficiency/chemically induced , Renal Insufficiency/genetics , Renal Insufficiency/pathology , Tumor Necrosis Factor-alpha/biosynthesisABSTRACT
BACKGROUND: Renal failure is a frequent and serious complication in patients with decompensated cirrhosis. OBJECTIVES: We aimed to evaluate the renal oxidative stress, cell damage and impaired cell function in animal model of cirrhosis. METHODS: Secondary biliary cirrhosis was induced in rats by ligation of the common bile duct. We measured TBARS, ROS and mitochondrial membrane potential in kidney as markers of oxidative stress, and activities of the antioxidant enzymes. Relative cell viability was determined by trypan blue dye-exclusion assay. Annexin V-PE was used with a vital dye, 7-AAD, to distinguish apoptotic from necrotic cells and comet assay was used for determined DNA integrity in single cells. RESULTS: In bile duct ligation animals there was significant increase in the kidney lipoperoxidation and an increase of the level of intracellular ROS. There was too an increase in the activity of all antioxidant enzymes evaluated in the kidney. The percentage viability was above 90% in the control group and in bile duct ligation was 64.66% and the dominant cell death type was apoptosis. DNA damage was observed in the bile duct ligation. There was a decreased in the mitochondrial membrane potential from 71.40% ± 6.35% to 34.48% ± 11.40% in bile duct ligation. CONCLUSIONS: These results indicate that intracellular increase of ROS cause damage in the DNA and apoptosis getting worse the renal function in cirrhosis.
Subject(s)
Apoptosis , Kidney/pathology , Liver Cirrhosis, Experimental/pathology , Oxidative Stress , Renal Insufficiency/pathology , Animals , Disease Models, Animal , Flow Cytometry , Kidney/enzymology , Liver Cirrhosis, Experimental/enzymology , Male , Rats , Rats, Wistar , Renal Insufficiency/enzymologyABSTRACT
INTRODUCTION: Ureteral obstruction is a common pathology and caused kidney fibrosis and dysfunction at late period. In this present, we investigated the antifibrotic and antiinflammatory effects of montelukast which is cysteinyl leukotriene receptor antagonist, on kidney damage after unilateral ureteral obstruction(UUO) in rats. MATERIALS AND METHODS: 32 rats divided four groups. Group 1 was control, group 2 was sham, group 3 was rats with UUO and group 4 was rats with UUO which were given montelukast sodium (oral 10 mg/kg/day). After 14 days, rats were killed and their kidneys were taken and blood analysis was performed. Tubular necrosis, mononuclear cell infiltration and interstitial fibrosis scoring were determined histopathologically in a part of kidneys; nitric oxide(NO), malondialdehyde(MDA) and reduced glutathione(GSH) levels were determined in the other part of kidneys. Urea-creatinine levels were investigated at blood analysis. Statistical analyses were made by the Chi-square test and one-way analysis of variance (ANOVA). RESULTS: There was no difference significantly for urea-creatinine levels between groups. Pathologically, there was serious tubular necrosis and fibrosis in group 3 and there was significantly decreasing for tubular necrosis and fibrosis in group 4(p<0.005). Also, there was significantly increasing for NO and MDA levels; decreasing for GSH levels in group 3 compared the other groups(p<0.005). CONCLUSION: We can say that montelukast prevent kidney damage with antioxidant effect, independently of NO.
Subject(s)
Acetates/therapeutic use , Cysteine/antagonists & inhibitors , Kidney/drug effects , Leukotriene Antagonists/therapeutic use , Quinolines/therapeutic use , Renal Insufficiency/prevention & control , Ureteral Obstruction/complications , Acetates/pharmacology , Animals , Creatinine/blood , Cyclopropanes , Fibrosis/prevention & control , Glutathione/analysis , Kidney/pathology , Leukotriene Antagonists/pharmacology , Leukotrienes , Lipid Peroxidation/drug effects , Male , Malondialdehyde/analysis , Nitric Oxide/analysis , Oxidative Stress/drug effects , Protective Agents/therapeutic use , Quinolines/pharmacology , Rats, Wistar , Renal Insufficiency/drug therapy , Renal Insufficiency/pathology , Reproducibility of Results , Sulfides , Treatment Outcome , Urea/bloodABSTRACT
Background Renal failure is a frequent and serious complication in patients with decompensated cirrhosis. Objectives We aimed to evaluate the renal oxidative stress, cell damage and impaired cell function in animal model of cirrhosis. Methods Secondary biliary cirrhosis was induced in rats by ligation of the common bile duct. We measured TBARS, ROS and mitochondrial membrane potential in kidney as markers of oxidative stress, and activities of the antioxidant enzymes. Relative cell viability was determined by trypan blue dye-exclusion assay. Annexin V-PE was used with a vital dye, 7-AAD, to distinguish apoptotic from necrotic cells and comet assay was used for determined DNA integrity in single cells. Results In bile duct ligation animals there was significant increase in the kidney lipoperoxidation and an increase of the level of intracellular ROS. There was too an increase in the activity of all antioxidant enzymes evaluated in the kidney. The percentage viability was above 90% in the control group and in bile duct ligation was 64.66% and the dominant cell death type was apoptosis. DNA damage was observed in the bile duct ligation. There was a decreased in the mitochondrial membrane potential from 71.40% ± 6.35% to 34.48% ± 11.40% in bile duct ligation. Conclusions These results indicate that intracellular increase of ROS cause damage in the DNA and apoptosis getting worse the renal function in cirrhosis. .
Contexto A falência renal é uma complicação grave e frequente em pacientes com cirrose descompensada. Objetivo Avaliar o estresse oxidativo, o dano ao DNA e alterações na função celular no rim em um modelo animal de cirrose. Métodos A cirrose biliar secundária foi induzida em ratos através da ligadura do duto biliar comum. Foi medido no rim o TBARS (substâncias que reagem ao ácido tiobarbitúrico), ERO (espécies reativas de oxigênio), o potencial de membrana mitocondrial e a atividade das enzimas antioxidantes. A viabilidade celular foi determinada utilizando o ensaio de exclusão do trypan-blue. Para distinguir células em apoptose ou necrose foram usados os marcadores: Anexina V-PE e 7-AAD e o ensaio cometa foi utilizado para determinar dano ao DNA. Resultados Em animais cirróticos houve um aumento significativo da lipoperoxidação no rim e na quantidade de ERO intracelular. Foi observado um aumento na atividade de todas as enzimas antioxidantes. A porcentagem de viabilidade celular foi superior a 90% no grupo controle e de 64,66% no grupo da ligadura do duto biliar. O padrão de morte celular predominante foi apoptose e houve dano ao DNA no grupo da ligadura do duto biliar. Observou-se uma redução no potencial de membrana mitocondrial no grupo da ligadura do duto biliar (34,48% ± 11,40%) em comparação aos controles (71,40% ± 6,35%). Conclusão Esses resultados parecem indicar que nos animais cirróticos ocorre um aumento no dano oxidativo e ao DNA levando as células renais à apoptose, o que contribui para a falência renal na cirrose. .
Subject(s)
Animals , Male , Rats , Apoptosis , Kidney/pathology , Liver Cirrhosis, Experimental/pathology , Oxidative Stress , Renal Insufficiency/pathology , Disease Models, Animal , Flow Cytometry , Kidney/enzymology , Liver Cirrhosis, Experimental/enzymology , Rats, Wistar , Renal Insufficiency/enzymologyABSTRACT
BACKGROUND: Rocky Mountain spotted fever (RMSF) is an increasingly important cause of preventable mortality in children in Sonora, Mexico. Although early treatment with tetracycline has shown to prevent fatal outcome, the disease remains a life-threatening condition, particularly for children. This study describes the clinical factors associated with pediatric mortality due to RMSF in Sonora, in order to guide healthcare practices. METHODS: This is a retrospective analysis of 104 children consecutively hospitalized at the major pediatric hospital of Sonora, diagnosed with RMSF between January 2004 and December 2013. Descriptive statistics and multiple logistic regression were used to identify risk factors for fatal outcome. RESULTS: The case fatality ratio in this cohort was 20.2%. Children were hospitalized after a median of 6 days from onset of symptoms including fever (100%), rash involving palms and soles (88.5%) and headache (79.8%); 90.4% of fatal cases had low platelet counts (<50,000/µL) and 33.3% showed serum creatinine concentrations above the normal value. Acute kidney injury increased mortality, odds ratio (OR(adj)) = 4.84, 95% confidence interval (CI): 1.2-16.2, as well as delay in treatment (≥ 5th day from onset) with doxycycline, OR(adj) = 2.62, 95% CI: 1.24-5.52 and hemorrhage, OR(adj) = 6.11, 95% CI: 1.89-19.69. CONCLUSIONS: RMSF is a public health problem in Sonora. Clinically, fatal cases differ from non-fatal cases in renal function and hemorrhagic manifestations, although these findings may occur too late for a timely intervention. First-line providers must be educated to harbor a timely suspicion of RMSF, and should provide empiric treatment with doxycycline when febrile patients first present for care.
Subject(s)
Renal Insufficiency/mortality , Renal Insufficiency/pathology , Rocky Mountain Spotted Fever/mortality , Rocky Mountain Spotted Fever/pathology , Adolescent , Animals , Anti-Bacterial Agents/therapeutic use , Child , Child, Preschool , Doxycycline/therapeutic use , Female , Humans , Infant , Infant, Newborn , Male , Mexico , Mortality , Prognosis , Renal Insufficiency/drug therapy , Retrospective Studies , Risk Factors , Rocky Mountain Spotted Fever/complications , Rocky Mountain Spotted Fever/drug therapy , Young AdultABSTRACT
BACKGROUND: Dyspepsia is highly prevalent and easily assessed in end-stage renal disease (ESRD) patients undergoing hemodialysis (HD) and is not a traditional predictor of malnutrition. We sought to establish an association between dyspeptic symptoms and nutritional status in ESRD patients undergoing maintenance HD. METHODS: We studied 106 ESRD patients on HD. Dyspepsia was assessed through the Porto Alegre Dyspeptic Symptoms Questionnaire (PADYQ). Scores equal to or greater than 6 classified patients as dyspeptic. Nutritional status was evaluated using serum chemistry, total body mass, muscle mass, and dietary intake. Nutritional status was compared between dyspeptic and non-dyspeptic patients. The association of PADYQ scores and the presence of dyspepsia with nutritional variables were tested. Multivariate analysis was performed to test dyspepsia as an independent predictor for dietary intake. RESULTS: There were 41 (38.7 %) dyspeptics. Protein intake (g/kg/day) and calorie intake (kcal/kg/day) were lower among dyspeptics compared to non-dyspeptics, 1.0 ± 0.5 vs 1.3 ± 0.5 (p = 0.01) and 23.0 ± 9.2 vs 27.4 ± 10.0 (p = 0.02), respectively. More dyspeptics than non-dyspeptics presenting protein-energy wasting based on protein and calorie intake, 41.4 vs 15.3 % (p = 0.01) and 68.2 vs 38.4 % (p = 0.02), respectively. PAQYQ score was negatively correlated with protein intake (r = - 0.20; p = 0.03) and calorie intake (r = - 0.19; p = 0.04). Dyspepsia was able to predict protein (b = - 0.26; p = 0.01) and calorie (b = - 4.42; p = 0.02) intake. CONCLUSIONS: Dyspepsia is associated with low protein and calorie intake. Screening of dyspeptic symptoms can be routinely performed aiming to improve HD patients' nutritional status.
Subject(s)
Dietary Proteins/pharmacology , Dyspepsia/etiology , Energy Intake/physiology , Nutritional Status/physiology , Renal Insufficiency/pathology , Adult , Aged , Diet , Dietary Proteins/administration & dosage , Female , Humans , Male , Middle Aged , Renal Dialysis , Risk FactorsABSTRACT
INTRODUCTION/OBJECTIVE: Ureteral obstruction is a common pathology and causes kidney fibrosis and dysfunction at late period. In this present study, we investigated the antifibrotic and antiinflammatory effects of hydrogen sulfide on kidney damage after unilateral ureteral obstruction (UUO) in rats. MATERIALS AND METHODS: 24 rats were divided into four groups. Group 1 was control, group 2 was sham, group 3 included rats with UUO and group 4 rats with UUO which were given sodium hydrogen sulfide (NaHS)-exogenous donor of hydrogen sulfide (intraperitoneally 56 µmoL/kg/day). After 14 days, rats were killed and their kidneys were taken and blood analysis was performed. Tubular necrosis, mononuclear cell infiltration and interstitial fibrosis were determined histopathologically in a part of the kidneys; nitric oxide (NO), malondialdehyde (MDA) and reduced glutathione (GSH) levels were determined in the other part of the kidneys. Urea-creatinine levels were investigated by blood analysis. Statistical analyses were made by the Chi-square test and one-way analysis of variance (ANOVA). RESULTS: There was no significantly difference for urea-creatinine levels among groups. Pathologically, there was serious tubular necrosis and fibrosis in group 3 and there was significantly decreasing of tubular necrosis and fibrosis in group 4 (p<0.005). Also, there was significantly increase of NO and MDA levels and decrease of GSH levels in group 3 compared to other groups (p<0.005). CONCLUSIONS: hydrogen sulfide prevents kidney damage with antioxidant and antiinflammatory effect.